TTFields Earns Japanese Approval in Unresectable Advanced/Recurrent NSCLC
A novel and milestone achievement in the realm of oncology, TTFields, has secured approval in Japan for addressing Unresectable Advanced/Recurrent NSCLC.
Refining Management of Immune-Checkpoint Inhibitor Toxicities in Melanoma
Efforts are ongoing towards refining strategies to curb Immune-Checkpoint Inhibitor Toxicities in Melanoma treatment.
FDA Grants Fast Track Designation to SRN-101 for Recurrent High-Grade Glioma
The FDA has fast-tracked SRN-101, a promising intervention for Recurrent High-Grade Glioma.
Novel Small Molecule Shows Early Activity in Pretreated Multiple Myeloma
Preliminary evidence has surfaced indicating the potent activity of a novel small molecule in Pretreated Multiple Myeloma.
Comparing Quality of Life Outcomes with Protons vs Photons in OPSCC
Current researches are delving into comparing the effectiveness of Protons and Photons in improving Quality of Life outcomes in OPSCC.
3 Things You Should Know About PSMA-Directed Imaging and Radioligand Therapy in Prostate Cancer
Significant insights have emerged concerning PSMA-Directed Imaging and Radioligand Therapy in Prostate Cancer.
